Biokarpet S.A (BIOKA) Fair Value & Analysis
Consumer Cyclical · GR · Market cap €39.5M
Fair value as of: Jul 24, 2026
From 15 valuation models · updated 18 days ago
Fair value updated Jul 24, 2026, revised from €7.46 to €4.84 (−35.2%) since Jun 25, 2026. Share price +2.7% over the past month.
Below-average quality, screening 187% undervalued on our models.
What matters now
- The price is below even our cautious bear case (€3.19). The market is more pessimistic than our downside scenario.
- Solid quality (46/100) at a price below fair value, the discount is the argument here, not the business quality.
- A fairly wide model range (€3.19 to €6.49) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 24, 2026.
How to read this chart
60‑month range €1.01 – €3.31 · fair‑value band €3.19 – €6.49 · the €1.68 price screens below the €4.84 fair value. Dashed = 300-day average. As of Jul 24, 2026.
Analysis
Biokarpet S.A (BIOKA) currently trades at €1.68, while our model-based Fair Value estimate is €4.84, implying the stock looks roughly 187.2% undervalued today. The Quality Score stands at 46/100 (below-average quality), in the Consumer Cyclical sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.
Over the trailing twelve months, Biokarpet S.A generated revenue of €213M at a net margin of 1.5%. Revenue grew 2.5% year over year. It earns a return on equity of 6.5%. The stock trades on a trailing P/E of 182.9. Fundamentals as of Jul 24, 2026
Our scenario range runs from €3.19 (bear case) to €6.49 (bull case); at €1.68, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 21% below its 52-week high and 16% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Cyclical peers we cover trades at -27% fair-value upside, at 187%, BIOKA screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 15 models by family
Widest divergence: Growth Earnings (€9.47) versus DCF Models (€0.6200). Highest evidence: ROIC Compounder (72).
Notify me when BIOKA reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 24, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 43 · Market factors (momentum, volatility) 44
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Biokarpet S.A. engages in the metallurgy, textile, and information technology sectors in Greece, rest of European union, and internationally. It produces and trades in handmade and machine-made carpets, moquettes, blankets, flokati rugs, and other products for flooring and home decoration.
Full company description
Biokarpet S.A. engages in the metallurgy, textile, and information technology sectors in Greece, rest of European union, and internationally. It produces and trades in handmade and machine-made carpets, moquettes, blankets, flokati rugs, and other products for flooring and home decoration. The company also offers linen and wall coverings for bed and bath; and wall to wall carpets and carpet tiles, as well as carpet cleaning and storage services. In addition, it produces and trades in aluminum profile products and related products; provides information systems services and consulting in software and software procurement, as well as engages in wholesale of computer machines and office equipment. Further, the company produces and distributes electricity through renewable sources. It operates a network of 50 stores, which includes 40 stores in Greece and 10 stores primarily in Romania, Bulgaria, Cyprus, Poland, and Albania, as well as offers its products online. The company was founded in 1950 and is headquartered in Athens, Greece.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2018 – FY2022 · reported fiscal years
Biokarpet S.A reported revenue of €231M in FY2022 versus €119M in FY2018, a compound +18.0%/yr. Reported net income was €9.0M in FY2022, compounding +169.4%/yr from FY2018.
Watch BIOKA: get an alert when its fair value changes →
Peer Group
Textile Manufacturing · 307 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Textile Manufacturing median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Textile Manufacturing stocks, each showing price versus our Fair Value estimate (as of Jul 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Shenzhou International Group 2313 | HK$44.40 | HK$75.65 | +70% |
| Tongkun Group 601233 | ¥23.56 | ¥14.53 | -38% |
| Inner Mongolia ERDOS Resources Co 600295 | ¥12.04 | ¥14.35 | +19% |
| Far Eastern New Century Corporation 1402 | 27.55 TWD | 28.72 TWD | +4% |
| K.P.R. Mill Limited KPRMILL | ₹1,083 | ₹467.49 | -57% |
| HMT (Xiamen) New Technical Materials Co 603306 | ¥78.00 | ¥11.85 | -85% |
| Zhejiang Orient Holdings 600120 | ¥5.18 | ¥2.21 | -57% |
| Vardhman Textiles Limited VTL | ₹602.20 | ₹437.53 | -27% |
| Isiklar Enerji ve Yapi Holding IEYHO | 174.20 TRY | 323.84 TRY | +86% |
| Shandong Fiberglass Group 605006 | ¥16.75 | ¥6.42 | -62% |
Compare Biokarpet S.A with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Cyclical stocks →
Frequently asked questions
Is Biokarpet S.A (BIOKA) overvalued or undervalued?
What is the fair value of BIOKA?
What is the quality score of BIOKA?
What is the revenue of Biokarpet S.A (BIOKA)?
What is the net profit margin of BIOKA?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Biokarpet S.A and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.